RAC1 and Alzheimer disease: Given prior evidence of neuro-immune circuit engagement in AD, we propose that neuronal CHN1 elevation may remodel Rac1-dependent axons, heighten pruriceptor excitability, and amplify neuropeptide release that skews cutaneous immunity (65, 66).